NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bolt Biotherapeutics

Bolt Biotherapeutics

Public
Redwood City, CaliforniaBiotechhttps://www.boltbio.com/

Bolt Biotherapeutics is now publicly traded

The data on this page reflects Bolt Biotherapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Feb 5, 2021

Last Round

Series C

Jul 1, 2020

Total Funding Raised

$429M

Company Overview

Bolt Biotherapeutics is a clinical-stage biopharmaceutical company that develops novel immunotherapies for the treatment of cancer using its proprietary Boltbody™ Immune-Stimulating Antibody Conjugate (ISAC) platform.

Sector

Biotech

AI Layer

Non-AI

Keywords

immuno-oncologyimmune-stimulating antibody conjugatesISACscancer immunotherapybiotech stockclinical-stage biotechsolid tumor treatmentantibody engineeringdrug discoverymyeloid biologybiopharma R&Dclinical trialpre-revenue biotech

Bolt Biotherapeutics Comparables

Compare Bolt Biotherapeutics with similar companies based on industry and business-model similarity.

Bolt Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Seven and Eight Biopharmaceuticals Inc.
77%
Ankyra Therapeutics
76%
Nammi Therapeutics
73%

Bolt Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOFeb 5, 2021
Series CJul 1, 2020
Series BFeb 5, 2019
Series ASep 1, 2016

Key People

Founding team and executive leadership

Grant Yonehiro

COO CBO, Chief Business Officer

Executive Team

Bolt Biotherapeutics Investors

Notable investors and investment history

Bolt Biotherapeutics investors
InvestorRounds
Surveyor CapitalSeries C
RA Capital ManagementSeries C
Nan Fung Life SciencesSeries B
Novo HoldingsSeries C, Series B, Series A
Pivotal bioVenture PartnersSeries C, Series B
Samsara BioCapitalSeries C
Rock Springs CapitalSeries C

Bolt Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bolt Biotherapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersRedwood City, California
Employee Range56
Year Founded2015
Last FundingJul 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.